Ivan de Kouchkovsky, MD
Quick facts
Phase 2 pipeline
- Hyperpolarized 13C,15N2-urea · Oncology
Hyperpolarized 13C,15N2-urea is a diagnostic imaging agent that uses hyperpolarized carbon-13 to enhance the visibility of metabolic processes in the body. - Hyperpolarized C13
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies